Stewart L. Einfeld

Stewart L. Einfeld

Auto-generated profile, based on publicly available information

Stewart L. Einfeld

University of Sydney

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2023 in European Child & Adolescent Psychiatry
Verified
Journal Article
Open access
PDF file
LRLauren Rice
Lauren Rice
LCLisa Cannon
Lisa Cannon
NDNavin Dadlani
Navin Dadlani
MCMelissa Mei Yin Cheung
Melissa Mei Yin Cheung
SEStewart L. Einfeld
Stewart L. Einfeld
EEElizabeth Elliott
Elizabeth Elliott
A better understanding of the endocannabinoid system and a relaxation in regulatory control of cannabis globally has increased interest in the medicinal use of cannabinoid-based products (CBP). We provide a systematic review of the rationale and current clinical trial evidence for CBP in the treatment of neuropsychiatric and neurodevelopmental disorders in children and adolescents. A systematic search of MEDLINE, Embase, PsycINFO, and the Cochrane Central Register of Trials was performed to identify articles published after 1980 about CBP for medical purposes in individuals aged 18 years or younger with selected neuropsychiatric or neurodevelopmental conditions. Risk of bias and quality of evidence was assessed for each article. Of 4466 articles screened, 18 were eligible for inclusion, addressing eight conditions (anxiety disorders (n = 1); autism spectrum disorder (n = 5); foetal alcohol spectrum disorder (n = 1); fragile X syndrome (n = 2); intellectual disability (n = 1); mood disorders (n = 2); post-traumatic stress disorder (n = 3); and Tourette syndrome (n = 3)). Only one randomised controlled trial (RCT) was identified. The remaining seventeen articles included one open-label trial, three uncontrolled before-and-after trials, two case series and 11 case reports, thus the risk of bias was high. Despite growing community and scientific interest, our systematic review identified limited and generally poor-quality evidence for the efficacy of CBP in neuropsychiatric and neurodevelopmental disorders in children and adolescents. Large rigorous RCTs are required to inform clinical care. In the meantime, clinicians must balance patient expectations with the limited evidence available.

3 February 2011
Verified
Book Chapter
Closed access
EEEric Emerson
Eric Emerson
SEStewart L. Einfeld
Stewart L. Einfeld
Challenging Behaviour - February 2011

3 February 2011
Verified
Book Chapter
Closed access
EEEric Emerson
Eric Emerson
SEStewart L. Einfeld
Stewart L. Einfeld
Challenging Behaviour - February 2011